Purpureocillium lilacinum (Thom) Luangsa-ard, Houbraken, Hywel-Jones & Samson is a ubiquitous, saprobic filamentous fungus commonly isolated from soil, decaying vegetation, insects, nematodes, and other environments. This fungus is an emergent pathogen that causes severe human infections, but is used as an important biological control agent against nematodes. 1−4 A recent comparative study of a few clinical isolates of this fungus with strains isolated from soil, insects, and nematodes using 18S rRNA gene, internal transcribed spacer (ITS), and partial translation elongation factor 1-α (TEF) sequences revealed that P. lilacinum is not related to Paecilomyces. Therefore, a new genus named Purpureocillium was proposed for the fungus, and the new combination Purpureocillium lilacinum (Thom) Luangsa-ard, Houbraken, Hywel-Jones & Samson was made for this species. 1−4 A few metabolites have been isolated from P. lilacinum, including the neutral peptides regarded as paecilotoxins 5, 6 and the novel pyridone alkaloid paecilomide. 7 The peptides exhibited moderate antimicrobial properties and strong uncoupling activity against rat liver mitochondria, 5, 6 while paecilomide was an inhibitor of acetylcholinesterase. 7 In our continuous search for calmodulin (CaM) ligands from fungi, 8−12 we have now studied P. lilacinum, isolated from a soil sample of a cave in Juxtlahuaca, State of Guerrero, Mexico, and obtained two xanthone−anthraquinone heterodimers, namely, acremoxanthone C 13 (1) and acremonidin A 14 (2) . Calmodulin is a small (148 residues), acidic, and highly conserved protein, possessing homologous N-and C-terminal globular domains connected by a flexible central linker. 15 Each globular domain contains two Ca 2+ binding sites of the helix− loop−helix (EF-hand) type. 16 Ca 2+ binding to the protein induces the exposure of its hydrophobic patches, allowing binding to specific proteins and adopting a compact globular structure wrapped around its targets. Calmodulin interacts with many cellular targets to regulate their function, resulting in modulation of a large number of Ca 2+ -dependent signal transduction processes including gene regulation, protein synthesis, ion channel function, cell motility, organelle tubulation, chemotaxis, and smooth muscle contraction, to mention a few. 17 Several synthetic or natural occurring compounds also bind to CaM in different domains, modifying its physiological function. Some of these compounds are used as valuable tools to study CaM-mediated pathways or as pharmacological agents for treating chronic or degenerative diseases. 18, 19 Thus, the discovery of new and more potent CaM inhibitors with a novel binding mode could lead to the discovery of new research tools or drugs with unique pharmacological properties.
Herein, we describe the isolation, absolute configuration, CaM binding properties, and docking studies of acremoxanthone A (1). Furthermore, a novel, sensible, and specific fluorescent biosensor of human CaM (hCaM T110C-mBBr), labeled at a site where classical inhibitors of the protein do not interact, was constructed and successfully applied to evaluate compounds 1 and 2.
■ RESULTS AND DISCUSSION
An extract prepared from the culture medium and mycelium of P. lilacinum quenched the fluorescence of the CaM biosensor hCaM M124C-mBBr 20 by 50%, suggesting the presence of one or more CaM ligands. Reversed-phase liquid chromatography of the active extract allowed the isolation of two CaM ligands, acremoxanthone C (1) and acremonidin A (2). The structures of 1 and 2 were determined by spectroscopic and spectrometric analyses and comparison with reported data. 13, 14 Acremoxanthone C (1) was recently isolated from an unidentified fungus of the Hypocreales order. The characterization of 1 was achieved by NMR analysis; the relative configuration at C-1′, C-14′, and C-11′ was designated on the basis of the ROESY experiment, which showed a correlation between the acetate C-18′ methyl group and H-13′. 13 All attempts to assign the absolute configuration at C-2 via the Mosher esters failed. In all cases, the G-ring opened under the basic conditions, yielding compound 2 and other minor products. Thus, the absolute configuration at C-2, C-3, C-1′, C-14′, and C-11′ could not be unambiguously established.
The affinity of 1 and 2 for CaM was assessed using the fluorescent biosensor hCaM M124C-mBBr; the fluorescence titration curves (λ ex 381 nm; λ em 415−550 nm) of hCaM M124C-mBBr were assembled as depicted in Figure 1 . The results showed that 1 and 2 bind to the protein with dissociation constants (K d ) of 18.25 ± 3.01 and 19.40 ± 3.15 nM, respectively, in a stoichiometric ratio of 1:1. These values were consistent with their higher affinity (70-fold) to the protein than CPZ (K d = 1.24 μM), a well-known classic CaM inhibitor used as positive control. Compounds 1, 2, and CPZ quenched the fluorescence of the biosensor with values of 47%, 48%, and 90%, respectively. The level of affinity to CaM of 1 and 2 is unusual, since most CaM antagonists bind to the protein with much lower affinity, usually in the micromolar range.
Considering the extraordinary affinity of 1 to CaM, we decided to complete its structural characterization by establishing its absolute configuration. Thus, molecular modeling calculations at the DFT B3LYP/DGDZVP level were undertaken 21, 22 in order to determine the calculated specific rotation and Sixteen stereoisomers, in two enantiomeric series, are conceivable for 1, since the bridgehead carbons (C-11′ and C-14′) can only be β-or α-oriented. The structure for each member of the β-series was built and minimized using the Spartan'02 software ( Figures S1 and S2 ). For all diastereoisomers a conformational search was performed applying the molecular mechanics Monte Carlo protocol, followed by geometry optimization for each generated conformer using DFT calculations at the B3LYP/DGDZVP level, as implemented in the Gaussian 09 software. The optical rotation calculations were performed for each fully minimized conformer within an energy window of 0−3 kcal/mol (Tables S1− Figure 1 . Fluorescence spectra and titration curves of hCaM M124C-mBBr (5 μM) to saturation ion Ca 2+ (10 mM). (A) 1, 18.25 nM; (B) 2, 19.40 nM; and (C) CPZ, 1.24 μM. Buffer was 10 mM potassium acetate (pH 5.1) at 37°C. Samples were excited at 381 nm, and emission spectra recorded from 415 to 550 nm. The absolute changes of maximal fluorescence emission were corrected for light-scattering effects and plotted against the ligands to total protein ratio (insets). S8). Once the results were Boltzmann-weighted, it was found that regardless of the absolute configuration of the C-2, C-3, and C-1′ stereogenic centers, the eight isomers (A−H) possessing the bridgehead carbon atoms β-oriented (11′S,14′R) had positive [α] D values, while those α-oriented (11′R,14′S) had negative values (Table S9) . In this regard, all reported xanthone−anthraquinone heterodimers of the acremoxanthone series possess a β-oriented C-11′−C-14′ bridgehead and positive [α] D values. Thus, the biosynthesis of this type of compound seems to be restricted to the β-oriented C-11′−C-14′ bridgehead isomers. 14,23−25 The calculated specific rotation data of those isomers having positive values were compared with the experimental value recorded for 1. According to the results in Table 1 , the [α] D value calculated for isomer A matched best with the experimental value for acremoxanthone C (1). This finding also implied that the absolute configurations at C-2, C-3, C-1′, C-11′, and C-14′ were R, R, S, S, and R, respectively ( Figure 2 ). Furthermore, the strong correlations between closely located H-1′ and H-15′α (distance = 2.86 Å) and H-15′β (distance = 2.44 Å) in the NOESY spectrum of 1 provided additional evidence for the S configuration at C-1′, ruling out stereoisomers E−H.
To reinforce the proposed stereochemical assignment for acremoxanthone A (1), a selection of experimental In order to the predict the binding site to CaM of 1 and 2, a theoretical molecular study of docking was undertaken using the program AutoDock 4.2. 26 The cocrystallized structure of CaM with TFP was used (PDB code 1A29). The docking of 1 and 2 with the cocrystallized structure of CaM-TFP showed a nonclassical interaction; that is, the binding pocket was different from that for CPZ and TFP, which occupy one or more protein domains, respectively. The predicted K i 's were 406.9 and 367.6 nM, respectively. The predicted binding site for 1 and 2, however, was similar to that of KAR-2, a vinblastine-derived antitumoral agent 27 that binds to CaM in a pocket between the N-and C-terminal globular domains like 1 and 2 theoretically do. KAR-2, 1, and 2 seem to interact with several common amino acid residues, mainly hydrophobic, including Phe19, Ala15, Val35, Leu39, Gln41, Phe68, Ala73, Phe92, Met109, Leu112, Glu114, and Thr146; in addition, 1 forms a hydrogen bond between 3-OH and Met72 (distance = 1.9 Å), and 2 forms a similar interaction between 3-OH and Met145 (distance = 3.8 Å). Both types of interactions (hydrophobic and hydrogen bonds) play an important role in the stabilization of the protein−ligand complex (Figure 4) . A docking study using the CaM-KAR-2 crystallized structure (PDB 1XA5) confirmed this supposition ( Figure S3 ). 2 , where J e is the coupling constant value measured from the experimental spectra and J c is the calculated constant value.
d Root-mean-square deviation, calculated from the equation ∑ i (MSE) i /n, where MSE i is the mean-squared error for each coupling constant and n is the total coupling constants to compare. (blue sticks) with CaM, using the crystallographic structure of the CaM (PDB code 1XA5). Details about the binding model of 1 and 2, the amino acids involved in the interaction (white sticks) with the ligand, and hydrogen bonds (green dashed lines) are shown in the right and left panel, respectively. This figure was prepared using LigPlot and PyMOL.
Next, the affinity of 1 to CaM was measured with the newly designed hCaMT110C-mBBr, which was conceived for detecting nonclassical inhibitors of CaM. Device hCaMT110C-mBBr was generated following a conventional strategy that comprised site-directed mutagenesis for replacing the strategic residues Thr110 by Cys, followed by specific labeling of the thiol-reactive group with the fluorophore mBBr. This position was selected for labeling considering that residue 110 of CaM is in an accessible surface area (ASA = 50.17 Ǻ2) in the α-helix structure of CaM far from the binding site of classical inhibitors, and it is not involved in Ca 2+ binding. The quantum efficiency of the hCaM T110C-mBBr device was ϕ = 0.303. Next, fluorescence titration curves with hCaM T110C-mBBr were constructed with saturating concentrations of 1 and CPZ (3.1 and 7.1 μM) in the presence of Ca 2+ (10 mM). The results indicated that the fluorescence quenching is about 63% and 20% for 1 and CPZ, respectively. Furthermore, a shift of fluorescence maximum to higher wavelengths (red-shift) is observed for compound 1. The higher percentage of quenching and the fluorescence maximum displacement caused by 1, in comparison with CPZ, revealed that it binds to the protein in a different site than classical inhibitors. 28 The last set of results provided experimental support concerning the unusual binding site of 1 to CaM as predicted by the docking study. Ligands that interact with a novel binding domain on CaM might not inhibit most of the modulatory properties of CaM. For example, Horvath et al. demonstrated that the drug KAR-2 interacted with a novel drug-binding domain on CaM, allowing the protein to interrelate with most of its physiological targets. Furthermore, they concluded that this feature confers to KAR-2 its specificity and lack of significant toxic side effects. 19 In summary, compounds 1 and 2 interact with CaM with higher affinity than CPZ, which is a classical inhibitor of the protein. The differences in quenching and the fluorescence maximum displacement caused by 1, in comparison with CPZ, as detected by the newly designed hCaM T110C-mBBr, revealed that it might bind to the protein in a different site than classical inhibitors. Indeed, docking studies predicted that the binding site of 1 and 2 is unusual, different from that of classical inhibitors, but similar to that of KAR-2. Thus, hCaM T110C-mBBr can efficiently detect nonclassical inhibitors of CaM, while hCaM M124C-mBBr is an efficient device for quickly identifying in a sensitive and reliable manner both classical and nonclassical ligands. 12, 24, 29, 12, 30, 31 This is the first report of xanthone−anthraquinone heterodimers in species of Paecilomyces or Purpureocillium genera.
■ EXPERIMENTAL SECTION
General Experimental Procedures. IR spectra were acquired using KBr disks in a Perkin-Elmer FT 59913 spectrophotometer. UV spectra were taken on a Shimadzu 160 UV spectrometer in CHCl 3 solution. The experimental optical rotations at the sodium D-line wavelength of pure compounds were recorded in CHCl 3 solution on a Perkin-Elmer 243 polarimeter at 23°C. NMR spectra, including NOE differential, COSY, HMBC, and HSQC experiments, were recorded in CDCl 3 or methanol-d 4 on a Varian Unity Plus 500 spectrometer or on a Bruker DMX500 spectrometer operating at either 500 MHz ( 1 H) or 125 MHz ( 13 C), using TMS as an internal standard. RP-HPLC was carried out with a Waters HPLC instrument equipped with a Waters 996 UV photodiode array detector (900) set at 247/365 nm, using a PurospherSTAR RP-18e column (4.6 mm × 250 mm) and a gradient system starting with 50% MeCN in water, to 80% MeCN in 15 min, and 100% MeCN over 30 min, at a flow rate of 3.0 mL/min. Control of equipment, data acquisition and processing, and management of chromatographic information were performed by the Millenium 32 software package (Waters). TLC analyses were performed on silica gel 60 F 254 plates (Merck), and visualization of plates was carried out using a Ce 2 (SO 4 ) 3 (10%) solution in H 2 SO 4 .
Fungal Material. The fungus was isolated from a soil collected in a cave in Juxtlahuaca (17°25′36″ N, 99°7′34″ W), State of Guerrero, Mexico, in 1998. A reference sample (MEXU 26014) of the isolate was deposited at the Herbario Nacional de Mexico (MEXU). Stock cultures of the fungus are stored in potato-dextrose agar (PDA) and monthly subcultured for preservation.
Fermentation, Extraction, and Isolation. The fungus P. lilacinum was grown in PDA Petri dishes for 15 days; then the agar was cut into pieces (1 cm 2 ) and inoculated in six 1.8 L Fernbach flasks, each containing 1.4 L of potato-dextrose broth (PDB). Inoculated flasks were incubated at room temperature for 21 days in static conditions. After incubation, the contents of the flasks were combined and filtered through cheesecloth. The separated mycelium was macerated with a mixture of CH 2 Cl 2 −MeOH (9:1), and the culture media was subjected to successive partitions with CH 2 Cl 2 . The mycelia and broth extracts were combined according to their chromatographic homogeneity and evaporated under reduced pressure to afford a yellow, oily extract (980 mg). The total extract was suspended in 400 mL of a mixture of MeCN−MeOH (1:1) and partitioned with nhexane (3 × 350 mL). The combined MeCN−MeOH fractions were dried in vacuo, and the resulting residue (350 mg) was dissolved in MeOH and subjected to RP-HPLC separation on a semipreparative Purospher column to yield 1 (115 mg, t R 26.2 min) and 2 (21 mg, t R 21.9 min). Construction of hCaM T110C-mBBr Biosensor. Cloning and subcloning were done as previously reported using the pGEM-T Easy Vector System I and vector pET12b with restriction enzymes NdeI and BamHI. 20 Amino acid substitutions were generated by overlapping PCR mutagenesis using the Quick Change Kit (Stratagene, La Jolla, CA, USA). The amount of plasmid pET12b-hCaM was 100 ng, and the amount of mutagenic oligonucleotides was 125 ng. PCR amplification included 25 cycles of denaturation at 95°C for 1 min, annealing using a temperature ramp from 45 to 60°C, a heating rate of 0.2°C/s, and polymerization at 68°C for 10 min, followed by one final extension step at 68°C for 10 min. Oligonucleotides used to generate the single mutant T110C were 5′-CGT CAC GTC ATG TGT AAC TTA GG-3′ and 5′-CCT AAG TTA CAC ATG ACG TGA CG-3′. After the mutagenesis experiments, the products of PCR amplification were digested with DpnI enzyme and transformed in DH5α competent cells. The sequence of construction and mutation was confirmed by nucleotide sequencing with an ABI PRISM 310 genetic analyzer (Applied Biosystems, Foster City, CA, USA). Plasmids (pET12b-hCaM T110C) were transformed into E. coli BL21-AI One Shot following the specifications of the kit's manufacturer.
Protein Purification of the Mutant hCaM T110C. A single colony of E. coli strain BL21-AI/pET12b-hCaM T110C was grown overnight in LB medium containing 100 mg/mL ampicillin with shaking at 37°C and inoculated into 500 mL of LB medium containing 100 mg/mL ampicillin, until the optical density of the culture at 550 nm reached between 0.8 and 1.0. Expression was induced by the addition of L-(+)-arabinose (0.2% w/v) overnight with shaking at 37°C. The cells were harvested by centrifugation (10 min, 4000g), resuspended in 50 mM Tris-HCl, 2 mM EDTA, 1 mM dithiothreitol (DTT), and 200 mg/mL egg white lysozyme at pH 7.5, and chilled on ice for 30 min. Resuspended cells were lysed by sonication, and cellular debris was removed by centrifugation for 15 min at 15000g. The supernatant was collected, and CaCl 2 and NaCl were added to final concentrations of 5 and 500 mM, respectively. The protein was purified using a Phenyl Sepharose CL-4B chromatographic column. Briefly, the supernatant was applied to the column preequilibrated with 50 mM Tris-HCl, 0.5 mM DTT, 0.1 mM CaCl 2 , and 500 mM NaCl at pH 7.5. The column was washed with loading buffer followed by the same with 1 mM EDTA and 150 mM NaCl. Finally, the protein was loaded on a cationic exchange column (Source Q, Amersham Biosciences) at pH 8.8 and eluted by a linear gradient of 40 min (0−100%) with 500 mM NaCl. Protein was collected in fractions and assessed for purity by gel electrophoresis.
Chemical Modification of Unique Reactive Cysteine of hCaM T110C Protein with mBBr. All fluorophore conjugation steps were typically carried out at room temperature. To protein at a concentration of 5−10 mg/mL was added 5 mM DTT by 12 h to reduce intramolecular disulfide bonds; then the mixture was washed on a gel filtration HR-100 column (Pharmacia, Biotech) to eliminate the excess DTT. A thiol-reactive fluorophore (20% in DMSO) was added in small aliquots to reach a final concentration of 10 molar excess and DMSO about 5%. Conjugation proceeded in the dark overnight at 4°C with shaking. Separation of protein from unreacted fluorophore was achieved by size-exclusion chromatography (Superdex 75). The efficiency of report group attachment was assessed by the reactivity of the protein against 5,5′-dithiobis(2-nitrobenzoic) acid, measuring the release of 2-nitrobenzoate. Next, protein concentration of labeled hCaM was determined with the bicinchoninic acid method. 32 Steady-State Fluorescence Bioassay (hCaM M124C-mBBr and hCaM T110C-mBBr biosensors). All measurements were conducted with an ISS-PC1 spectrofluorometer (ISS, Champaign, IL, USA) with sample stirring at 37°C. The fluorescent biosensors hCaM M124C-mBBr and hCaM T110C-mBBr (1 mM), obtained as previously described, 20 were incubated in the buffer (50 mM NaOAc [pH 5.1] and 10 nM CaCl 2 ); then, after 5 min the ligand dissolved in MeOH (10 nM) was added. Fluorescence emission spectra were acquired with excitation and emission slit widths of 4 and 8 nm, respectively. The excitation wavelength was 381 nm, and emission wavelengths were measured in a range of 415−550 nm. The fractional saturation (y) of the hCaM M124C-mBBr-ligand and hCaM T110-mBBr-ligand complexes was calculated by changes in fluorescence upon ligand binding according to y = (F − F 0 )/(F ∞ − F 0 ), where F ∞ represents the fluorescence intensity at full saturation with the ligand, and y is plotted as a function of the Ca resources to carry out computational calculations through the KanBalam system.
